The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Inorganic Arsenic and Human Prostate Cancer
Open accessAbstract
OBJECTIVE: We critically evaluated the etiologic role of inorganic arsenic in human prostate cancer. DATA SOURCES: We assessed data from relevant epidemiologic studies concerning environmental inorganic arsenic exposure. Whole animal studies were evaluated as were in vitro model systems of inorganic arsenic carcinogenesis in the prostate. DATA SYNTHESIS: Multiple studies in humans reveal an association between environmental inorganic arsenic exposure and prostate cancer mortality or incidence. Many of these human studies provide clear evidence of a dose-response relationship. Relevant whole animal models showing a relationship between inorganic arsenic and prostate cancer are not available. However, cellular model systems indicate arsenic can induce malignant transformation of human prostate epithelial cells in vitro. Arsenic also appears to impact prostate cancer cell progression by precipitating events leading to androgen independence in vitro. CONCLUSION: Available evidence in human populations and human cells in vitro indicates that the prostate is a target for inorganic arsenic carcinogenesis. A role for this common environmental contaminant in human prostate cancer initiation and/or progression would be very important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P., & Waalkes, M. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10907 · Cited by 559
Self-citationWei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., & Fukushima, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1387 · Cited by 222
Huang, R.-N., & Lee, T.-C. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0031 · Cited by 101
Androgen Receptor Mutations in Carcinoma of the Prostate: Significance for Endocrine Therapy
Culig, Z., Klocker, H., Bartsch, G., & Hobisch, A. (2001) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200101040-00001 · Cited by 50
Cited by
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
Arsenic and human health effects: A review
Mohammed Abdul, K. S., Jayasinghe, S. S., Chandana, E. P. S., Jayasumana, C., & De Silva, P. M. C. S. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.09.016 · Cited by 907
Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action
De Coster, S., & van Larebeke, N. (2012) · Journal of Environmental and Public Health · doi:10.1155/2012/713696 · Cited by 617
Rahaman, M. S., Rahman, M. M., Mise, N., Sikder, M. T., Ichihara, G., Uddin, M. K., Kurasaki, M., & Ichihara, S. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117940 · Cited by 584
The Current State of Water Quality and Technology Development for Water Pollution Control in China
Qu, J., & Fan, M. (2010) · Critical Reviews in Environmental Science and Technology · doi:10.1080/10643380802451953 · Cited by 268
Metadata
- Authors
- Benbrahim-Tallaa, L., & Waalkes, M. P.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-02
- Volume
- 116
- Issue
- 2
- Pages
- 158-164
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2058071169
- Cited by
- 194
- References
- 5
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.